Clinical Trials on Bone Marrow Examination in Argentina

Total 324 results

Incyte Corporation
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)

Polycythemia Vera

United States, Canada, France, Italy, United Kingdom, China, Belgium, Germany, Spain, Turkey, Japan, Australia, Korea, Republic of, Netherlands, Russian Federation, Argentina, Thailand, Hungary
Pontifical Catholic University of Argentina

Completed

Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America

Osteoporosis

Argentina
Fundaleu

Recruiting

Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase (AST)

CML

Argentina
Hospital Italiano de Buenos Aires

Enrolling by invitation

Multicenter Validation Study of an Artificial Intelligence Tool for Automatic Classification of Chest X-rays

Pneumothorax | Pleural Effusion | Bone Fracture | Consolidation | Opacity

Argentina
Universidad Nacional de Córdoba

Completed

Periodontal Disease and Post-menopausal Osteoporosis

Osteoporosis | Osteopenia | Periodontal Disease

Argentina
Pfizer

Completed

A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

Osteoporosis

Argentina
Zimmer Biomet

Completed

A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.

Tumor | Neuroma | Mandibular Fractures | Treacher Collins Syndrome | Facial Fracture | Fibrous Dysplasia | Hemifacial Microsomia | Miller Syndrome | Osteoma of Mandibular Condyle | Cleft Face | Nager Syndrome

Argentina
Celgene

Recruiting

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions (INDEPENDENCE)

Primary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis

France, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
Bio Sidus SA

Unknown

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

Postmenopausal Osteoporosis With Pathological Fracture

Argentina
AbbVie

Completed

A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review (METER)

Myelofibrosis

Argentina, Australia, Brazil, Canada, Colombia, Greece, Italy, Mexico, Poland, Portugal, Romania, Taiwan, Turkey, United States
AbbVie

Active, not recruiting

Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

Myelofibrosis (MF)

United States, Argentina, Australia, Brazil, Bulgaria, Chile, Hungary, Israel, Italy, Japan, Spain, Sweden, Turkey, Korea, Republic of
Hospital Italiano de Buenos Aires

Completed

Drug Interactions and Hip Fracture Risk in Older Adults

Hip Fractures

Argentina
Universidad Nacional de Rosario

Completed

Effectiveness of Dextrose Injection for Osgood-Schlatter Disease

Osgood-Schlatter Disease

Argentina
Warner Chilcott
Sanofi

Terminated

Bone Microarchitecture in Osteopenic Postmenopausal Women

Osteoporosis

United States, Argentina
Pfizer
Eli Lilly and Company

Completed

Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

Cancer Pain | Bone Metastasis

China, Spain, Korea, Republic of, Australia, Israel, Japan, Poland, Slovakia, Romania, Austria, Hungary, United Kingdom, Argentina, Brazil, Chile, Czechia
Geron Corporation

Recruiting

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Myelofibrosis

United States, Australia, Italy, India, United Kingdom, Israel, Taiwan, Poland, Malaysia, Argentina, Spain, Turkey, Belgium, Germany, Austria, Brazil, Bulgaria, Colombia, Denmark, France, Georgia, Hungary, Korea, Republic of, Portugal, ... and more
Hospital Italiano de Buenos Aires

Active, not recruiting

Effect of Spinae Erector Block (ESP) and Gabapentin on Recovery and Length of Stay in Adolescent Spinal Fusion Patients

Adolescent Idiopathic Scoliosis

Argentina
Drugs for Neglected Diseases
PhinC Development

Completed

Pharmacokinetic Drug-Drug Interaction Study

Chagas Disease

Argentina
Bayer

Completed

Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in Argentina

Chagas' Disease

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Active, not recruiting

Nifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease Treatment

Chagas Disease

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires
The Hospital for Sick Children; Thrasher Research Fund; Universidad Nacional... and other collaborators

Completed

Population Pharmacokinetics of Benznidazole in Children With Chagas Disease

Chagas Disease

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Completed

Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease (LACTBENZ)

Chagas Disease | Lactation

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Completed

Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease (LACTNFX)

Chagas Disease | Lactation

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Institutional Registry of Hip Fracture in the Elderly

Hip Fracture

Argentina
Liga Panamericana de Asociaciones de Reumatologia...

Recruiting

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors (PREJAK)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis

Argentina
Novartis Pharmaceuticals

Completed

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

Low and Int 1-risk Myelodysplastic Syndrome

Germany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
Amgen

Completed

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Bone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer

Spain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
BioMarin Pharmaceutical

Completed

Lifetime Impact Study for Achondroplasia (LISA)

Achondroplasia

Argentina, Brazil, Colombia
Hospital de Niños R. Gutierrez de Buenos Aires

Completed

Congenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evaluation in Chagas Disease Treated Children

Chagas Cardiomyopathy | Chagas Disease

Argentina
Warner Chilcott

Completed

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

Osteopenia

United Kingdom, Argentina, Australia, Canada, France, Germany, Switzerland
Bristol-Myers Squibb

Active, not recruiting

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

Argentina, Canada, France, Germany, Italy, Korea, Republic of, Poland, United States, Australia, China, Czechia, Denmark, Greece, Hong Kong, Japan, Spain, Sweden
Novartis Pharmaceuticals

Completed

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

CHRONIC MYELOGENOUS LEUKEMIA

Canada, Australia, Spain, Argentina, France, Brazil
Drugs for Neglected Diseases
LAT Research

Completed

Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease (Pop PK Chagas)

Chagas' Disease

Argentina
Kartos Therapeutics, Inc.

Recruiting

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment (BOREAS)

Primary Myelofibrosis (PMF) | Post-Polycythemia Vera MF (Post-PV-MF) | Post-Essential Thrombocythemia MF (Post-ET-MF)

United States, Korea, Republic of, Germany, Australia, Hungary, France, Spain, Italy, Taiwan, Thailand, Brazil, Poland, Turkey, Israel, Portugal, Romania, Argentina, Bulgaria, Canada, Croatia, Czechia, Lithuania, Mexico, Philippines, United... and more
RFS Pharma, LLC

Completed

Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV

HIV Infections

Argentina
Eli Lilly and Company
TransPharma Medical

Completed

A Study for the Transdermal Application of Teriparatide

Osteoporosis

Hungary, Romania, Mexico, Argentina, Estonia
Pedro Cahn
Merck Sharp & Dohme LLC

Terminated

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

HIV Infections

Argentina
Austral University, Argentina

Unknown

Re-linkage to Care of Patients With Hepatitis C

Viral Hepatitis C

Argentina
Shire

Completed

Open Label Extension (TRES)

Osteoporosis

United States, Argentina
Hospital Nacional Profesor Alejandro Posadas

Recruiting

Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation. (HINDIP)

Inflammation | Hyponatremia | Dengue

Argentina
Laboratorio Elea Phoenix S.A.
Drugs for Neglected Diseases

Recruiting

Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease (NuestroBen)

Chagas Disease

Argentina
Ministry of Public Health, Argentina
Centers for Disease Control and Prevention; Pan American Health Organization

Enrolling by invitation

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Yellow Fever

Argentina
Bristol-Myers Squibb

Recruiting

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions (ELEMENT-MDS)

Myelodysplastic Syndromes

Canada, United States, China, Australia, France, Greece, Hungary, Germany, Italy, Czechia, Poland, Mexico, Spain, Brazil, Colombia, India, Argentina, Puerto Rico
Pfizer

Completed

Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

Chronic Myeloid Leukemia

United States, Canada, Spain, China, Australia, Singapore, Korea, Republic of, France, Hong Kong, Netherlands, Turkey, Poland, Japan, United Kingdom, Argentina, Colombia, Hungary, Russian Federation, South Africa, Belgium, Brazil, Chil... and more
University of Miami
National Institute of Mental Health (NIMH); Fundacion Huesped, Buenos Aires... and other collaborators

Completed

Positive Connections: COPA2

Human Immunodeficiency Virus

Argentina
Novartis Pharmaceuticals

Terminated

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection (REVERT)

Recurrent Hepatitis C

Argentina
ViiV Healthcare
GlaxoSmithKline

Completed

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Infection, Human Immunodeficiency Virus

Argentina
Novartis Pharmaceuticals

Completed

Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib (LASOR)

Chronic Myelogenous Leukemia

China, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
Bayer

Completed

Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

Chagas Disease

Argentina
Bayer

Completed

Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients

Chagas Disease

Argentina

Clinical Trials on Bone Marrow Examination in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations